Anthem BCBSLow ImpactAdministrative
[Georgia] Lenalidomide is now available with end‑to‑end REMS support
Published May 3, 2026
AI Summary
Lenalidomide (a cancer medication) is now available with end-to-end Risk Evaluation and Mitigation Strategy (REMS) support in Georgia. This provides comprehensive support for the required safety program associated with this high-risk medication.
Action Required
Oncology providers and billing teams should be aware that lenalidomide now has enhanced REMS support available. Contact the insurer or REMS program for specific enrollment or utilization procedures if prescribing this medication.
Plan Types
All Plans
States
GA
Specialties
oncology, hematology